Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03404635 · ClinicalTrials.gov registry record
Monotherapy Anticoagulation To Expedite Home Treatment of Venous Thromboembolism
A clinical trial of Venous Thromboembolism, sponsored by Indiana University.
- Completed
- Registry status
- 1,300
- Enrollment target
- 2
- Study locations
NCT03404635: Completed study of Venous Thromboembolism, sponsored by Indiana University.
NCT03404635 is a study of Venous Thromboembolism that has completed, run by Indiana University. The registered enrollment target is 1,300 participants, below the 6,268-participant average among 47 other Venous Thromboembolism trials with a reported enrollment target (79% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03404635, a study of Venous Thromboembolism, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 1,300 participants
- Enrollment target
- 2
- Study locations
Study Summary
Prospective, multicenter observational study, of the effectiveness of a standard of care protocol implemented to enhance home treatment of VTE. Study population will be selected as part of usual care as eligible for home treatment. Study personnel will travel to participating institutions to qualify the sites, deliver a Powerpoint® lecture to introduce the protocol, meet and train site principal investigators, emergency physicians and research personnel on the implementation of the protocol as part of usual clinical care, and data collection methods for a quality assurance registry with plans to use the data collected in this registry in future publications. Follow-up will be 30 days using medical records and/or telephone interview to assess for primary outcomes of bleeding or VTE recurrence.
Primary Outcome
Re-hospitalization for \> 24 hours due to VTE recurrence or bleeding
Conditions Studied
Interventions
- DRUG Apixaban
- DRUG Rivaroxaban
Study Locations (2)
Indiana
- Eskenazi Health System - Indianapolis
- Indiana University Health Methodist Hospital - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,300 participants |
| Start Date | 2017-08-04 |
| Est. Completion | 2020-05-08 |
What the finished NCT03404635 record still lists
NCT03404635 is an observational study that tracks outcomes without assigning an intervention. Its 1,300 participants enrollment target places it among the larger protocols in the corpus, below the 6,268-participant average among 47 other Venous Thromboembolism trials with a reported enrollment target (79% lower).
The record links to 1 condition, with Venous Thromboembolism appearing as the primary indexed condition, and to 2 interventions - of which Apixaban is the first listed.
NCT03404635 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT03404635 about?
NCT03404635 is a clinical study titled "Monotherapy Anticoagulation To Expedite Home Treatment of Venous Thromboembolism". Prospective, multicenter observational study, of the effectiveness of a standard of care protocol implemented to enhance home treatment of VTE. Study population will be selected as part of usual care as eligible for home treatment. Study personnel will travel to participating institutions to qualify...
What is the current status of trial NCT03404635?
This trial is currently completed. The enrollment target is 1,300 participants. The study started on 2017-08-04. Estimated completion is 2020-05-08.
What conditions does trial NCT03404635 study?
This clinical trial studies the following conditions: Venous Thromboembolism.
What interventions are being tested in trial NCT03404635?
The interventions under investigation include: Apixaban (DRUG), Rivaroxaban (DRUG).
Who is sponsoring clinical trial NCT03404635?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03404635 being conducted?
This trial has 2 study locations across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Venous Thromboembolism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03404635's enrollment target sits among peer trials
1,300 17th of 47 higher than 31 of 47 other Venous Thromboembolism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Venous Thromboembolism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Glioblastoma Remote Monitoring and Care - Research Protocol
RECRUITING · NA
-
Venous Thromboembolism Prevention in Outpatients With Glioma
RECRUITING · Phase 2
-
PRospective Evaluation of Peripartum Anticoagulation ManaGement for ThrOmboembolism
RECRUITING
-
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
RECRUITING · NA
-
Computerized Registry of Patients With Venous Thromboembolism (RIETE)
RECRUITING
-
Evaluation of the SCALED (SCaling AcceptabLE cDs)
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04474223 · 1,300 participants · Phase 3
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)
- NCT04792684 · 1,300 participants
Collection of Samples USOPTIVAL Study
- NCT05166694 · 1,300 participants · NA
Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions
- NCT05282654 · 1,300 participants · NA
Real-time Symptom Monitoring Using ePROs to Prevent Adverse Events During Care Transitions
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI